ISSN 1016-5169 | E-ISSN 1308-4488
Telmisartan-Induced Myotoxicity İn Patients With Essential Hypertension [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. Ahead of Print: TKDA-22893 | DOI: 10.5543/tkda.2023.22893

Telmisartan-Induced Myotoxicity İn Patients With Essential Hypertension

Süleyman Cihan Kara, Uğur Canpolat
Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Türkiye

Drug-related muscular adverse effects are relatively common among some groups of drugs such as statins, and steroids. However, these adverse effects are not well known for angiotensin receptor blockers (ARBs). It is proposed that telmisartan and irbesartan may cause myotoxicity via an increased PPAR-gamma activity. Herein, we presented 2 hypertensive patients in whom telmisartan-induced myotoxicity was observed. Thus, physicians should remember that telmisartan and some other ARBs can also cause myopathy. Possible drug-drug interactions should be considered in case of concomitant prescription of these agents with other myopathic drugs.

Keywords: Angiotensin receptor blocker, myotoxicity, telmisartan

How to cite this article

Corresponding Author: Uğur Canpolat, Türkiye
Manuscript Language: English

Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2023 Archives of the Turkish Society of Cardiology

Kare Publishing is a subsidiary of Kare Media.